Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||
|---|---|---|---|---|---|---|
| DAOL-CHINABIO | −2.65% | −4.56% | −13.72% | −1.28% | −6.88% | −14.77% |
| UCHI | −2.69% | −3.16% | −12.26% | −1.92% | −3.98% | −8.53% |
| BCARE | +1.99% | +5.09% | +8.23% | +8.14% | +17.30% | +15.27% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| DAOL-CHINABIO | UCHI | |
|---|---|---|
| Held by both | ||
| WuXi Biologics | 9.80% | 9.94% |
| Innovent | 4.88% | 8.62% |
| Sino Biopharmaceutical | 4.55% | 4.03% |
| Genscript Biotech Corp Class H | 3.22% | 3.90% |
 Wuxi AppTec | 3.20% | 8.42% |
| Only in DAOL-CHINABIO | ||
| CSPC Pharmaceutical Group | 6.71% | N/A |
| JD Health International | 6.39% | N/A |
| Alibaba Health Information T… | 3.34% | N/A |
| Shandong Weigao Group Medica… | 2.86% | N/A |
| Only in UCHI | ||
 BeOne | N/A | 9.29% |
 Jiangsu Hengrui Pharmaceutic… | N/A | 5.66% |
| Akeso | N/A | 5.51% |
| Shenzhen Mindray Bio-Medical… | N/A | 2.12% |
29 Jan 2026 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| BCARE | +15.27% | 16.19% | 0.94 |
| UCHI | −8.53% | 30.24% | −0.28 |
| DAOL-CHINABIO | −14.77% | 35.69% | −0.41 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | DAOL-CHINABIO | UCHI | BCARE |
|---|---|---|---|
Fund details | |||
| Fund size | 73.32 million | 693 million | 4,712 million |
| Inception date | 29 Jan 2026 | 25 Feb 2021 | 29 Aug 2007 |
| Master fund | Hang Seng Biotech Index ETF | กองทุนที่ลงทุนหลายกอง (Global X China Biotech, Kraneshares MSCI All China Health Care Index) | Wellington Global Health Care Equity Fund |
| Dividend policy | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | |||
| Risk level | 7 | 7 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | 73.46% | 89.92% | 47.41% |
Minimum purchase and redemption | |||
| First purchase | 1 THB | 0.01 THB | 500 THB |
| Subsequent purchase | 1 THB | 0.01 THB | 500 THB |
| Redemption (amount) | No minimum | 0.01 THB | No minimum |
| Redemption (units) | No minimum | No minimum | No minimum |
| Balance (amount) | No minimum | No minimum | No minimum |
| Balance (units) | 100 units | No minimum | No minimum |
Order cut-off and redemption payment | |||
| Buy before | 13:30 | 15:30 | 15:30 |
| Redeem before | 13:30 | 14:00 | 15:30 |
| Redemption paid | T+3 | T+4 | T+4 |
